Provision of potentially teratogenic medications to female veterans of childbearing age

Medical Care

Volumn 48, Issue 9, 2010, Pages 834-842

  Schwarz, Eleanor Bimla ^a,b,c   Longo, Lisa S ^d   Zhao, Xinhua ^e   Stone, Roslyn A ^b,e   Cunningham, Francesca ^f   Good, Chester B ^c,e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Veterans Affairs Pharmacy Benefits Management Services   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Veterans Affairs Center for Medication Safety   (United States)

Author keywords

contraception; medication safety; preconception counseling; women

Indexed keywords

RETINOID; TERATOGENIC AGENT;

ADULT; ARTICLE; CONTRACEPTION; DRUG CLASSIFICATION; FAMILY PLANNING; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HEALTH CENTER; HUMAN; MARRIAGE; MENTAL DISEASE; PATIENT COUNSELING; PREGNANCY; PREGNANCY TEST; PRESCRIPTION; PRIORITY JOURNAL; VETERAN;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; DRUG PRESCRIPTIONS; FAMILY PLANNING SERVICES; FEMALE; FORMS AND RECORDS CONTROL; HUMANS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; RETROSPECTIVE STUDIES; TERATOGENS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; YOUNG ADULT;

EID: 77955981837     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181e57946     Document Type: Article

References (22)

1. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep. 2008;57: 1-32.
2. Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects\Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008;57:1-5.
3. Centers for Disease Control and Prevention (CDC). Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects\United States, 2003. MMWR Morb Mortal Wkly Rep. 2007;56:25-29.
4. US Food and Drug Administration. Fedl Regist. 1980;44:37434-37467.
5. Schwarz EB, Maselli J, Norton M, et al. Prescription of teratogenic medications in United States ambulatory practices. Am J Med. 2005; 118:1240-1249.
6. Schwarz EB, Postlethwaite DA, Hung YY, et al. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med. 2007;147: 370-376.
7. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191:398-407.
8. Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf. 2006;15:537-545.
9. D'Angelo D, Williams L, Morrow B, et al. Preconception and interconcep-tion health status of women who recently gave birth to a live-born infant\Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ. 2007;56:1-35.
10. Office of Policy and Planning, Department of Veterans Affairs, Women veterans: Past, present and future,September 2007, Available at, http://www1.va.gov/womenvet/docs/WomenVetHistory.pdf, Accessed March 15, 2010.
11. National Center for Veterans Analysis and Statistics. Veteran population 2007. Available at: http://www1.vagov/VETDATA/Demographics/Demographics.asp. Accessed December, 18, 2009.
12. Frank O, Bianchi PG, Campana A. The end of fertility: Age, fecundity and fecundability in women. JBiosoc Sci. 1994;26:349-368.
13. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
14. Micromedex Healthcare Series [database online]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc; 2006. Available at: http://www.thomsonhc.com/ hcs/librarian.
15. Physicians' Desk Reference. Oradell, NJ: Medical Economics Co; 2006.
16. Schreiber CA, Harwood BJ, Switzer GE, et al. Training and attitudes about contraceptive management across primary care specialties: A survey of graduating residents. Contraception. 2006;73:618-622.
17. Spencer AL, Kern LM. Primary care program directors' perceptions of women's health education: A gap in graduate medical education persists. J Womens Health (Larchmt). 2008;17:549-556.
18. Henderson JT, Weisman CS, Grason H. Are two doctors better than one? Women's physician use and appropriate care. Womens Health Issues. 2002;12:138-149.
19. Hillemeier MM, Weisman CS, Chase GA, et al. Women's preconcep-tional health and use of health services: Implications for preconception care. Health Serv Res. 2008;43:54-75.
20. Schwarz EB, Santucci A, Borrero S, et al. Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Res A Clin Mol Teratol. 2009;85:858-863.
21. Weisman CS, Maccannon DS, Henderson JT, et al. Contraceptive counseling in managed care: Preventing unintended pregnancy in adults. Womens Health Issues. 2002;12:79-95.
22. Postlethwaite D, Trussell J, Zoolakis A, et al. A comparison of contraceptive procurement pre-and post-benefit change. Contraception. 2007; 76:360-365.